Non-small cell lung cancer market to gain over $20 billion in value by 2025, says GlobalData
The non-small cell lung cancer (NSCLC) market across the eight major markets (8MM) of the US, France, Germany, Italy, Spain, the UK, Japan, and China, is set to rise from $6.